CSIR’s cancer drug enters clinical trials

  • A CSIR lab has received approval to conduct clinical trials of a new drug in pancreatic cancer patients.
  • Indian Institue of Integrative Medicine, Jammu is a drug research laboratory that works under the Council of Scientific & Industrial Research.
  • This approval has been given by the New Drugs Division of Central Drugs Standard Control Organization (CDSCO).
  • This drug has been created using the content from the leaves of Indian white cedar.
  • Globally, pancreatic cancer causes more than 2.5 lakh deaths annually.
  • This cancer is considered as one of the untreatable cancer types, because of its very late diagnosis.
READ  Girish Chandra Murmu becomes first Lieutenant Governor of J&K